Delcath Systems, Inc. Share Price

Delcath Systems, Inc. Share Price

NASDAQ: DCTH | Small Cap
$14.02
-$0.61 (-4.14%) Last updated on 30 Oct, 2026 | 22:46 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Delcath Systems, Inc. Stock Performance

Open
$14.41
Prev. Close
$14.63
Circuit Range
N/A
Day Range
$14.01 - $14.41
Year Range
$8.13 - $17.40
Volume
7,846
Average Traded
$14.22

Delcath Systems, Inc. Share Price Today

As of 30 October 2026, Delcath Systems, Inc.'s share price is $14.02. The stock opened at $14.41, compared to its previous close of $14.63. During today's trading session, Delcath Systems, Inc.'s share price traded between $14.01 and $14.41, with an average price of $14.21. Over the past 52 weeks, the stock has recorded a high of $17.40 and a low of $8.13. In terms of performance, Delcath Systems, Inc.'s share price has risen by 35.07% over the last six months and is up 42.55% on a year-on-year basis.

Delcath Systems, Inc. Share Price Chart

Line chart of the Delcath Systems, Inc. price trend over the selected period. The price fell overall, ranging from 14.01 to 14.52, ending at 14.02.
$14.01$14.41
L
Show Current Price
H

Delcath Systems, Inc. Stock Fundamentals & Key Indicators

Market Cap
$502.21M
PE Ratio (TTM)
954.87
Dividend Yield
0.00%
EPS (TTM)
$0.02
Revenue (TTM)
$85.23B
Return On Equity (TTM)
0.44%
Profit Margin
3.17%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
221.69%

Delcath Systems, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$20.56$20.73$24.99$29.13
Net Profit$0.83-$1.90-$1.07$2.67
Net Profit Margin4.04%-9.17%-4.28%9.17%
Income ChangeN/A-328.92%43.68%349.53%

Delcath Systems, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$2.72$2.07$37.21$85.23
Net Profit-$36.51-$47.68-$26.39$2.70
Net Profit Margin-1342.28%-2303.38%-70.92%3.17%
Income ChangeN/A-30.59%44.65%110.23%

About Delcath Systems, Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Delcath Systems, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$15.73
$14.01
-12.27%
Sep 2026
$16.47
$15.97
-2.50%
Aug 2026
$12.48
$16.38
+34.14%
Jul 2026
$12.61
$12.21
-3.02%
Jun 2026
$10.89
$12.59
+16.68%
May 2026
$10.61
$10.79
+3.95%
Apr 2026
$9.43
$10.38
+11.85%
Mar 2026
$8.71
$9.28
+4.33%
Feb 2026
$9.88
$8.89
-10.33%
Jan 2026
$10.05
$9.92
-1.64%
Dec 2025
$9.58
$10.09
+3.86%
Nov 2025
$9.70
$9.71
-1.27%

DCTH Share Price FAQs